Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Antiretroviral Regimens in Treatment-Naive HIV-1 Infected Subjects
2008-003364-19Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Reyataz + Norvir + Truvada with Isentress + Truvada (2 arms). Primary endpoint: Virologic suppression at Week 24. Started Nov 2008; status: completed.
02
Drugs
atazanavirritonaviremtricitabine + tenofovir disoproxilraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-003364-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003364-19.